Form 4: Voyager Therapeutics Director James A. Geraghty Granted Stock Options

Director James A. Geraghty receives stock options from Voyager Therapeutics under the 2015 Stock Option and Incentive Plan.

Summary

• James A. Geraghty, a director of Voyager Therapeutics, Inc., was granted stock options to purchase 24,000 shares of common stock on June 5, 2024.
• The options were issued under the company's 2015 Stock Option and Incentive Plan, as part of the director compensation policy.
• The exercise price of the options is $8.70 per share.
• The options vest upon the earlier of the one-year anniversary of the grant date (June 5, 2024) or the date of the next annual meeting of stockholders, contingent upon continued service as a director.
• The options expire on June 5, 2034.

Sentiment

Score: 7

Explanation: The document reflects a routine grant of stock options, which is generally viewed neutrally to positively as it aligns director interests with shareholders. There are no indications of negative news or concerns.

Positives

• The grant of stock options aligns the director's interests with those of the shareholders.
• The vesting schedule incentivizes continued service as a director.

Industry Context

Stock option grants are a common form of compensation for directors of publicly traded companies, aligning their interests with shareholders and incentivizing long-term value creation.

Comparison to Industry Standards

• Director compensation packages, including stock options, vary widely across the biotechnology industry depending on company size, stage of development, and performance.
• Comparing Voyager Therapeutics' director compensation to that of similar-sized gene therapy companies like Sarepta Therapeutics or Bluebird Bio would provide a more detailed benchmark.

Stakeholder Impact

• Shareholders may view the stock option grant positively as it incentivizes the director to work towards increasing shareholder value.
• The director benefits from the potential future value of the stock options.

Key Dates